Correlation Between Scpharmaceuticals and Passage Bio
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Passage Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Passage Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Passage Bio, you can compare the effects of market volatilities on Scpharmaceuticals and Passage Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Passage Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Passage Bio.
Diversification Opportunities for Scpharmaceuticals and Passage Bio
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Scpharmaceuticals and Passage is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Passage Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Passage Bio and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Passage Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Passage Bio has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Passage Bio go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Passage Bio
Given the investment horizon of 90 days Scpharmaceuticals is expected to generate 0.69 times more return on investment than Passage Bio. However, Scpharmaceuticals is 1.44 times less risky than Passage Bio. It trades about 0.01 of its potential returns per unit of risk. Passage Bio is currently generating about -0.03 per unit of risk. If you would invest 399.00 in Scpharmaceuticals on August 30, 2024 and sell it today you would lose (25.00) from holding Scpharmaceuticals or give up 6.27% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Passage Bio
Performance |
| Timeline |
| Scpharmaceuticals |
| Passage Bio |
Scpharmaceuticals and Passage Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Passage Bio
The main advantage of trading using opposite Scpharmaceuticals and Passage Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Passage Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Passage Bio will offset losses from the drop in Passage Bio's long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Passage Bio vs. Ikena Oncology | Passage Bio vs. Eliem Therapeutics | Passage Bio vs. HCW Biologics | Passage Bio vs. Tempest Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |